GEN is investing in a biotechnology start-up RS Research, developing novel drugs for cancer patients
GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a leading speciality pharmaceutical company is investing in RS Araştırma Eğitim...
top of page
- Aug 24, 2021
- 3 min
GEN and SULFATEQ Sign Definitive Collaboration Agreement
SULFATEQ and GEN sign definitive collaboration agreement to develop a therapy for Alzheimer’s Disease and additional Neurodegenerative...
447 views
- Nov 12, 2019
- 1 min
We Gained The Research and Development Center Status
GEN received R&D Center Status from Turkey’s Ministry of Industry and Technology.
91 views
bottom of page